Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2011 1
2016 1
2019 6
2020 8
2021 6
2022 21
2023 8
2024 6
2025 15
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Venditti A, Palmieri R, Maurillo L, Röllig C, Wierzbowska A, de Leeuw D, Efficace F, Curti A, Ngai LL, Tettero J, Adès L, Almeida A, Bullinger L, Dennis M, Esteve J, Ferrara F, Heuser M, Huls G, Lübbert M, Mehta P, Montesinos P, Pabst T, Récher C, Rossi G, Russell N, Sierra J, Stauder R, Vey N, Walter RB, Wang E, Nier S, Martins CG, Ossenkoppele G. Venditti A, et al. Among authors: palmieri r. Blood Adv. 2025 May 13;9(9):2207-2220. doi: 10.1182/bloodadvances.2024013744. Blood Adv. 2025. PMID: 39913928 Free PMC article. Review.
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
Guolo F, Fianchi L, Martelli MP, Lussana F, Grimaldi F, Pilo F, Rondoni M, Filì C, Minetto P, Capelli D, Chiusolo P, Breccia M, Mastaglio S, Bernardi M, Bocchia M, Fumagalli M, Galimberti S, Mancini V, Piccioni AL, Maurillo L, Fracchiolla NS, Palmieri R, Vetro C, Papayannidis C, Brunetti L, Sperotto A, Gigli F, Zappasodi P, Mulé A, Patti C, Borlenghi E, Dargenio M, Lessi F, Cerrano M, Cilloni D, Isidori A, Lunghi M, Alati C, Gurrieri C, Riva C, Marconi G, Lotesoriere I, Gatani S, Scattolin AM, Caizzi M, Perrone S, Billio A, Gherlinzoni F, Mannelli F, Gottardi M, Cairoli R, Candoni A, Ferrara F, Pagano L, Lemoli RM, Venditti A, Todisco E. Guolo F, et al. Among authors: palmieri r. Am J Hematol. 2025 Dec;100(12):2293-2304. doi: 10.1002/ajh.70083. Epub 2025 Sep 24. Am J Hematol. 2025. PMID: 40990091 Free PMC article. Clinical Trial.
Editorial: Measurable residual disease in hematologic malignancies.
Buccisano F, Palmieri R, Guzman ML, Galimberti S. Buccisano F, et al. Among authors: palmieri r. Front Oncol. 2023 May 10;13:1204393. doi: 10.3389/fonc.2023.1204393. eCollection 2023. Front Oncol. 2023. PMID: 37234991 Free PMC article. No abstract available.
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Marconi G, Petracci E, Lanzarone G, Vetro C, Martelli MP, Papayannidis C, Audisio E, Minetto P, Riva C, Guolo F, Martini G, Zappasodi P, Vincenzo F, Gigli F, Griguolo D, Rondoni M, Ciotti G, Borlenghi E, Ciccone N, Palumbo FE, Nanni J, Mattei D, Bernardi M, Cignetti A, Zingaretti C, Vertogen B, Cerchione C, Lanza F, Cilloni D, Brunetti L, Palmieri R, Curti A, Giannini MB, Todisco E; AVALON research group; Fracchiolla N, Martinelli G. Marconi G, et al. Among authors: palmieri r. Am J Hematol. 2025 Apr;100(4):708-711. doi: 10.1002/ajh.27591. Epub 2025 Jan 20. Am J Hematol. 2025. PMID: 39831709 Free PMC article.
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.
Zaza A, Zardo G, Banella C, Tucci S, de Marinis E, Gentile M, Travaglini S, Divona M, Ottone T, Castelli G, Cerio AM, Angelini DF, Faraoni I, Palmieri R, Niscola P, Ammatuna E, Venditti A, Nervi C, Voso MT, Catalano G, Noguera NI. Zaza A, et al. Among authors: palmieri r. Leukemia. 2025 Nov;39(11):2708-2720. doi: 10.1038/s41375-025-02738-9. Epub 2025 Sep 10. Leukemia. 2025. PMID: 40931045 Free PMC article.
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.
Vetro C, Garibaldi B, Grimaldi F, Chiusolo P, Filì C, Riva C, Cardinali V, Franciosa M, Pilo F, Palmieri R, Esposito L, Menotti D, Perrone S, Mulè A, Alati C, Vigna E, Dargenio M, De Luca G, Sperotto A, Tanasi I, Papayannidis C, Molica M, Minetto P, Battipaglia G, Memoli M, Salutari P, Brunetti L, Todisco E, Lotesoriere I, Isidori A, Palumbo GA, Annunziata M, Gottardi M, Gentile M, Martelli MP, Capelli D, Martino M, Rossi M, Ferrara F, Venditti A, Romani C, Galimberti S, Candoni A, Fianchi L, Pagano L, Marconi G, Lemoli RM, Di Raimondo F, Billio A, Palumbo FE, Pane F, Duminuco A, Guolo F. Vetro C, et al. Among authors: palmieri r. Blood Cancer J. 2025 Oct 26;15(1):181. doi: 10.1038/s41408-025-01394-7. Blood Cancer J. 2025. PMID: 41139766 Free PMC article. No abstract available.
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.
Palmieri R, Guolo F, Fianchi L, Ferrara F, Minetto P, Martelli MP, Riva C, Chiusolo P, Rondoni M, Capria S, Minotti C, Pilo F, Perrone S, Corbingi A, Grimaldi F, De Luca G, Fili C, Alati C, Mannelli F, Lessi F, Marchesi F, Brunetti L, Capelli D, Piccioni AL, Vetro C, Palumbo FE, Mazzone C, Sperotto A, Luzi G, Dargenio M, Mariani S, Cerrano M, Mulè A, Di Veroli A, Meddi E, Moretti F, Papayannidis C, Isidori A, Ferrari A, Galimberti S, Cilloni D, Breccia M, Lanza F, Gottardi M, Cairoli R, Candoni A, Pagano L, Todisco E, Lemoli RM, Venditti A, Buccisano F. Palmieri R, et al. Blood Adv. 2026 Feb 24;10(4):1126-1133. doi: 10.1182/bloodadvances.2025017089. Blood Adv. 2026. PMID: 41346286 Free PMC article.
74 results